Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index-Reference-Cited by-同舟云学术

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index

Published:2016-11-03 Issue:3 Volume:37 Page:369-376
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Bachofner Jacqueline A.¹²,Valli Piero V.¹²,Kröger Arne¹²,Bergamin Irina³,Künzler Patrizia³,Baserga Adriana⁴,Braun Dominique⁵⁶,Seifert Burkhardt⁷,Moncsek Anja¹²,Fehr Jan⁵,Semela David³,Magenta Lorenzo⁴,Müllhaupt Beat¹²,Terziroli Beretta-Piccoli Benedetta⁴,Mertens Joachim C.¹²

Affiliation:

1. Division of Gastroenterology and Hepatology; University Hospital Zürich; Zürich Switzerland

2. Swiss HPB Center; University Hospital Zürich; Zürich Switzerland

3. Division of Gastroenterology and Hepatology; Hospital St. Gallen; St. Gallen Switzerland

4. Epatocentro Ticino; Lugano Switzerland

5. Division of Infectious Diseases; University Hospital Zürich; Zürich Switzerland

6. Institute of Medical Virology; University of Zurich; Zurich Switzerland

7. Division of Biostatistics; Institute of Social and Preventive Medicine Zürich; University of Zürich; Zürich Switzerland

Funder

Gilead Sciences

AbbVie

FormVi Foundation

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13256/fullpdf

Reference23 articles.

1. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives;Asselah;Liver Int,2016

2. EASL recommendations on treatment of hepatitis C 2015;European Association for Study of L;J Hepatol,2015

3. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus;PANEL A I H G;Hepatology,2015

4. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis;European Association for Study of L, Asociacion Latinoamericana Para El Estudio Del H;J Hepatol,2015

5. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis;Sandrin;Ultrasound Med Biol,2003

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal coagulative necrosis of the liver in a patient with sustained virologic response to anti-hepatitis C virus therapy;Radiology Case Reports;2024-04

2. Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis;BMC Gastroenterology;2024-01-30

3. Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host’s Immunity;International Journal of Molecular Sciences;2023-12-23

4. No gender differences in the 24 month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy;2023-12-02

5. The effect of direct-acting antivirals (DAA) on confirmed noninvasive fibrous parameters in chronic hepatitis C patients;Anatolian Current Medical Journal;2023-10-27